Evidence map›Paper›PMID 33131239›Full record

ArticleHaematologica2020

COVID-19 and sickle cell disease.

Laurel A Menapace, Swee Lay Thein

Registry-linked trialAbstract read
In one paragraph

Article in Haematologica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05153044 (Severe Acute Respiratory Syndrome CoV 2 Seroprevalence Survey and Vaccination Coverage in the Sickle Cell Population in Ile-De-France), which is not on this map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05153044 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Severe Acute Respiratory Syndrome CoV 2 Seroprevalence Survey and Vaccination Coverage in the Sickle Cell Population in Ile-De-France

TypeinterventionalSponsorAssistance Publique - Hôpitaux de ParisRan2021 to 2022Enrolled880ConditionsSickle Cell DiseaseArmssevere acute respiratory syndrome CoV-2 serology
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Frequency, subtypes distribution, and risk factors ofNew microbes and new infections · 2023
    Article
  7. Evidence-based management of pregnant women with sickle cell disease in high-income countries.Hematology. American Society of Hematology. Education Program · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The Trilogy of SARS-CoV-2 in Pediatrics (Part 1): Acute COVID-19 in Special Populations.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2021
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Laurel A MenapaceSickle Cell Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Swee Lay TheinSickle Cell Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA. sl.thein@nih.gov.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Immunocompromised HostAnemia, Sickle CellBetacoronavirusCoronavirus InfectionsCOVID-19Disease ManagementHumansPandemicsPneumonia, ViralSARS-CoV-2

Identifiers

PMID33131239
PMCPMC7604559

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.